tetano
Editor, Senior Moderator
Nano Lett
. 2020 Jun 17.
doi: 10.1021/acs.nanolett.0c02278. Online ahead of print.
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Qiangzhe Zhang[SUP] 1 [/SUP], Anna Honko[SUP] 2 [/SUP], Jiarong Zhou[SUP] 1 [/SUP], Hua Gong[SUP] 1 [/SUP], Sierra N Downs[SUP] 2 [/SUP], Jhonatan Henao Vasquez[SUP] 2 [/SUP], Ronnie H Fang[SUP] 1 [/SUP], Weiwei Gao[SUP] 1 [/SUP], Anthony Griffiths[SUP] 2 [/SUP], Liangfang Zhang[SUP] 1 [/SUP]
Affiliations
Abstract
We report cellular nanosponges as an effective medical countermeasure to the SARS-CoV-2 virus. Two types of cellular nanosponges are made of the plasma membranes derived from human lung epithelial type II cells or human macrophages. These nanosponges display the same protein receptors, both identified and unidentified, required by SARS-CoV-2 for cellular entry. It is shown that, following incubation with the nanosponges, SARS-CoV-2 is neutralized and unable to infect cells. Crucially, the nanosponge platform is agnostic to viral mutations and potentially viral species, as well. As long as the target of the virus remains the identified host cell, the nanosponges will be able to neutralize the virus.
Keywords: COVID-19; broad spectrum; cell membrane; coronavirus; nanosponge.
. 2020 Jun 17.
doi: 10.1021/acs.nanolett.0c02278. Online ahead of print.
Cellular Nanosponges Inhibit SARS-CoV-2 Infectivity
Qiangzhe Zhang[SUP] 1 [/SUP], Anna Honko[SUP] 2 [/SUP], Jiarong Zhou[SUP] 1 [/SUP], Hua Gong[SUP] 1 [/SUP], Sierra N Downs[SUP] 2 [/SUP], Jhonatan Henao Vasquez[SUP] 2 [/SUP], Ronnie H Fang[SUP] 1 [/SUP], Weiwei Gao[SUP] 1 [/SUP], Anthony Griffiths[SUP] 2 [/SUP], Liangfang Zhang[SUP] 1 [/SUP]
Affiliations
- PMID: 32551679
- DOI: 10.1021/acs.nanolett.0c02278
Abstract
We report cellular nanosponges as an effective medical countermeasure to the SARS-CoV-2 virus. Two types of cellular nanosponges are made of the plasma membranes derived from human lung epithelial type II cells or human macrophages. These nanosponges display the same protein receptors, both identified and unidentified, required by SARS-CoV-2 for cellular entry. It is shown that, following incubation with the nanosponges, SARS-CoV-2 is neutralized and unable to infect cells. Crucially, the nanosponge platform is agnostic to viral mutations and potentially viral species, as well. As long as the target of the virus remains the identified host cell, the nanosponges will be able to neutralize the virus.
Keywords: COVID-19; broad spectrum; cell membrane; coronavirus; nanosponge.